Showing results (281-290 of 303) with videos related to
Sort By:
Pageof 31
Cardiology in the Young|March 30, 2023
Developmental care pathway for hospitalised infants with CHD: on behalf of the Cardiac Newborn Neuroprotective Network, a Special Interest Group of the Cardiac Neurodevelopmental Outcome CollaborativeAmy J Lisanti, Dorothy J Vittner, Jennifer Peterson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyAmar Gajjar, Anita Mahajan, Mohamed Abdelbaki, et al.Neuro-Oncology|April 13, 2019
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trialSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAmar Gajjar, Anita Mahajan, Tejus Bale, et al.Neuro-Oncology|October 11, 2017
Pediatric low-grade gliomas: next biologically driven stepsDavid T W Jones, Mark W Kieran, Eric Bouffet, et al.The Lancet. Oncology|October 27, 2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A Robertson, Grzegorz Nalepa, Feng-Chun Yang, et al.Neuro-Oncology|September 30, 2016
Pediatric low-grade gliomas: implications of the biologic eraRoger J Packer, Stephan Pfister, Eric Bouffet, et al.The Lancet. Oncology|April 12, 2021
Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization GroupDaniel C Bowers, Lisanne C Verbruggen, Leontien C M Kremer, et al.Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.The Lancet. Oncology|May 21, 2018
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trialGiles W Robinson, Vasilisa A Rudneva, Ivo Buchhalter, et al.Pageof 31